Avalyn Pharma Inc. (AVLN)

Avalyn Pharma Inc. Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2025	Dec 31, 2024
Debt / Equity Ratio	-0.01	-0.01	-
Debt / EBITDA Ratio	-0.02	-0.02	-
Debt / FCF Ratio	-0.02	-0.02	-
Net Debt / Equity Ratio	0.57	0.57	0.63
Net Debt / EBITDA Ratio	1.46	1.46	1.85
Net Debt / FCF Ratio	1.67	1.67	2.28
Quick Ratio	9.82	9.82	12.65
Return on Equity (ROE)	35.70%	35.70%	28.50%
Return on Assets (ROA)	-57.23%	-57.23%	-39.95%
Return on Capital Employed (ROCE)	-67.80%	-67.80%	-49.39%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).